These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27908759)

  • 1. Cathepsin nanofiber substrates as potential agents for targeted drug delivery.
    Ben-Nun Y; Fichman G; Adler-Abramovich L; Turk B; Gazit E; Blum G
    J Control Release; 2017 Jul; 257():60-67. PubMed ID: 27908759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-Triggered Morphological Transition of Peptide Nanostructures for Tumor-Targeted Drug Delivery and Enhanced Cancer Therapy.
    Cao M; Lu S; Wang N; Xu H; Cox H; Li R; Waigh T; Han Y; Wang Y; Lu JR
    ACS Appl Mater Interfaces; 2019 May; 11(18):16357-16366. PubMed ID: 30991000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMP-9 triggered self-assembly of doxorubicin nanofiber depots halts tumor growth.
    Kalafatovic D; Nobis M; Son J; Anderson KI; Ulijn RV
    Biomaterials; 2016 Aug; 98():192-202. PubMed ID: 27192421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
    Azaryan AV; Hook VY
    Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foot-and-mouth disease virus-like particles as integrin-based drug delivery system achieve targeting anti-tumor efficacy.
    Yan D; Teng Z; Sun S; Jiang S; Dong H; Gao Y; Wei Y; Qin W; Liu X; Yin H; Guo H
    Nanomedicine; 2017 Apr; 13(3):1061-1070. PubMed ID: 27993721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases.
    Dheer D; Nicolas J; Shankar R
    Adv Drug Deliv Rev; 2019; 151-152():130-151. PubMed ID: 30690054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanospheres of doxorubicin as cross-linkers for a supramolecular hydrogelation.
    Xue Q; Ren H; Xu C; Wang G; Ren C; Hao J; Ding D
    Sci Rep; 2015 Mar; 5():8764. PubMed ID: 25739554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
    Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
    Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembling surfactant-like peptide A6K as potential delivery system for hydrophobic drugs.
    Chen Y; Tang C; Zhang J; Gong M; Su B; Qiu F
    Int J Nanomedicine; 2015; 10():847-58. PubMed ID: 25670898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide Nanomaterials for Drug Delivery Applications.
    Pentlavalli S; Coulter S; Laverty G
    Curr Protein Pept Sci; 2020; 21(4):401-412. PubMed ID: 31893991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smart Nanotransformers with Unique Enzyme-Inducible Structural Changes and Drug Release Properties.
    Bellat V; Lee HH; Vahdat L; Law B
    Biomacromolecules; 2016 Jun; 17(6):2040-9. PubMed ID: 27180972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacious anticancer drug delivery mediated by a pH-sensitive self-assembly of a conserved tripeptide derived from tyrosine kinase NGF receptor.
    Moitra P; Kumar K; Kondaiah P; Bhattacharya S
    Angew Chem Int Ed Engl; 2014 Jan; 53(4):1113-7. PubMed ID: 24338837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An implantable active-targeting micelle-in-nanofiber device for efficient and safe cancer therapy.
    Yang G; Wang J; Wang Y; Li L; Guo X; Zhou S
    ACS Nano; 2015 Feb; 9(2):1161-74. PubMed ID: 25602381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanofiber-based delivery of therapeutic peptides to the brain.
    Mazza M; Notman R; Anwar J; Rodger A; Hicks M; Parkinson G; McCarthy D; Daviter T; Moger J; Garrett N; Mead T; Briggs M; Schätzlein AG; Uchegbu IF
    ACS Nano; 2013 Feb; 7(2):1016-26. PubMed ID: 23289352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrospun micelles/drug-loaded nanofibers for time-programmed multi-agent release.
    Yang G; Wang J; Li L; Ding S; Zhou S
    Macromol Biosci; 2014 Jul; 14(7):965-76. PubMed ID: 24634305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Phe-Phe Motif for Peptide Self-Assembly in Nanomedicine.
    Marchesan S; Vargiu AV; Styan KE
    Molecules; 2015 Nov; 20(11):19775-88. PubMed ID: 26540034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.
    Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F
    ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacious hepatoma-targeted nanomedicine self-assembled from galactopeptide and doxorubicin driven by two-stage physical interactions.
    Ding J; Xiao C; Li Y; Cheng Y; Wang N; He C; Zhuang X; Zhu X; Chen X
    J Control Release; 2013 Aug; 169(3):193-203. PubMed ID: 23247039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.